Connor, Clark & Lunn Investment Management (CC&L)’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,765
Closed -$24K 1281
2022
Q2
$24K Buy
1,765
+394
+29% +$9.22K ﹤0.01% 1016
2022
Q1
$71K Buy
+1,371
New +$60.6K ﹤0.01% 994
2019
Q4
Sell
-1,804
Closed -$178K 1133
2019
Q3
$178K Sell
1,804
-150
-8% -$14K ﹤0.01% 878
2019
Q2
$245K Buy
1,954
+142
+8% +$15.4K ﹤0.01% 864
2019
Q1
$158K Sell
1,812
-105
-5% -$7.7K ﹤0.01% 844
2018
Q4
$116K Buy
1,917
+1,106
+136% +$77.2K ﹤0.01% 896
2018
Q3
$66K Buy
+811
New +$62.2K ﹤0.01% 896
2016
Q1
Sell
-509
Closed -$40K 916
2015
Q4
$40K Buy
509
+136
+36% +$67.1K ﹤0.01% 795
2015
Q3
$251K Buy
+373
New +$265K ﹤0.01% 618
2014
Q1
Sell
-88
Closed -$72K 796
2013
Q4
$72K Sell
88
-325
-79% -$245K ﹤0.01% 707
2013
Q3
$326K Buy
413
+12
+3% +$9.86K ﹤0.01% 412
2013
Q2
$367K Buy
+401
New +$339K ﹤0.01% 396

Other funds holding MTEM

Connor, Clark & Lunn Investment Management (CC&L)'s MTEM Position: Q3 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 1,765 shares — an estimated $24K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MTEM in Q2 2013 and held it in 12 quarters. The position peaked at $367K in Q2 2013. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 1,765 Molecular Templates, Inc. shares in Q3 2022, an estimated $24K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Molecular Templates, Inc. position peaked at $367K in Q2 2013.
  • 58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.